Back

A new clinical risk score for left atrial low voltage areas (LVAs) prediction: the P.A.L.A.H score

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation (4) Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Athina Mpatsouli

Evangelismos Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Radiofrequency catheter versus cryoballoon ablation for left atrial box isolation in patients with atrial fibrillation: a propensity score-matched analysis
Doctor M. Esato (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution
Doctor S. Hussain (London, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of contact force (CF)-guided catheter ablation in atrial fibrillation (AF): an updated systematic review and meta-analysis
Miss O. Dairo (London, GB)
Abstract Slides Video
Presentation thumbnail
Impact of sex on procedural characteristics, safety and clinical outcomes of pulsed-field ablation for pulmonary vein isolation
Mr F. Jordan (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Ablation of visual spatiotemporal dispersion added to pulmonary vein isolation in persistent atrial fibrillation.
Doctor E. Franco (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation (4)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Clinical risk scores and left atrial low voltage areas in atrial fibrillation
thumbnail
Congress Presentation
Echocardiographic predictors of low-voltage zones in the left atrium in patients undergoing atrial fibrillation ablation
thumbnail
Congress Presentation
Endocardial low voltage areas have a significantly reduced success rate after ablation of persistent atrial fibrillation: a prospective randomized trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources